| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |